Consumer
The AnapnoGuard solution has been introduced by several Israeli hospitals in order to reduce complications caused by ventilators.
The funding will also help get much-needed therapies to patients faster.
The updated version of the company's system includes automatic alerts when the wearer's glucose is too high or too low.
Consumers can pay a $60 annual fee to get video consultations and individualized plans to address their migraines.
Device owners in participating states will soon receive enrollment notifications, while public health authorities may automatically have Exposure Notification apps generated for them.
Also: Abbott sells 150 million of its rapid, app-paired COVID-19 test to the White House; Platform launches for chronic disease patients juggling multiple providers.
Roundup: UK rehab centre offers robotics equipment for patients, new electronic discharge summaries…
Also, health tech investments in Dubai and India explored.
The consumer genomics company's existing offering, called AncestryHealth, sold clinician-ordered tests that were not cleared or approved by the FDA.
After declaring bankruptcy at the beginning of 2019, the Canadian company sold some of its patents to Honeywell.
Major pharmacies and services say they're unaffected by USPS troubles so far, but some online platforms that rely on the service are worried about their patients and long-term business.